TORONTO, March 2, 2011 — York University researchers have zeroed in on a genetic process that may allow ovarian cancer to resist chemotherapy.
Researchers in the university’s Faculty of Science & Engineering studied a tiny strand of our geneti…
Nanotechnology may open a new door on the treatment of liver cancer, according to a team of Penn State College of Medicine researchers. They used molecular-sized bubbles filled with chemotherapy drugs to prevent cell growth and initiate cell death i…
A breakthrough by scientists at Queen’s University Belfast could help reduce heart failure in cancer patients around the world, and ultimately increase survival rates.
Scientists at Queen’s Centre for Vision and Vascular Science have discovered …
COLUMBUS, Ohio — Scientists have found that a synthetic molecule they designed can block activation of a gene in liver cancer cells, halting a process that allows some of those cancer cells to survive chemotherapy.
Without the interference of t…
Chemotherapy, while an effective cancer treatment, also brings debilitating side effects such as nausea, liver toxicity and a battered immune system.
Now, a new way to deliver this life-saving therapy to cancer patients ― getting str…
Researchers from Ohio State University found that a common pain relief medication seems to increase the effectiveness of a drug used to treat skin cancer. Experiments in mice showed that the combination of celecoxib — a prescription-only non-steroidal anti-inflammatory drug (NSAID) — and a cream commonly used to treat nonmelanoma skin cancer was up to 35 percent more effective in reducing the number of skin cancer tumors than treating such lesions with the cream alone.